Procurement Summary
Country: Italy
Summary: Negotiated Procedure for the Supply of Various Active Ingredients: Colistimethate Sodium, Adalimumab, Tafasitamab, Factor Viii from Recombinant Dna (Turoctocog Alfa Pegylate)), Deutivacaftor/Tezacaftor/Va...
Deadline: 30 Apr 2026
Posting Date: 24 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140055676
Document Ref. No.: Niguarda_2026_BT_159
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 3181572.35
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Negotiated Procedure for the Supply of Various Active Ingredients: Colistimethate Sodium, Adalimumab, Tafasitamab, Factor Viii from Recombinant DNA (Turoctocog Alfa Pegylate)), Deutivacaftor/Tezacaftor/Vanzacaftor, Amivantamab, Sodium Hydroxide, Immunoglobulin Anti Hepatitis B, Lazertinib, Talquetamab, Fluorouracil and Iopamidol Product Categories: pharmaceutical products, cardiac prostheses, galenic solutions.
Earnest Money : 3.181.572, 35 € Published Date : 23/04/2026 Submission Date : 30/04/2026 12:00
Documents
Tender Notice